Copertina

Impact of pre‐stenting and bladder dranaige on intrapelvic pressure during retrograde intrarenal surgery

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Sezgin Yeni, Hakan Kilicarslan, Gokhan Ocakoglu, Burhan Coskun, Mehmet Cagatay Cicek, Kadir Omur Gunseren, Ismet Yavascaoglu, Onur Kaygisiz
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2025
Soggetti:	BJUI Compass
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Outcomes and considerations for retrograde intrarenal surgery (RIRS) in the setting of multiple and large renal stones (>15 mm) in children: Findings from multicentre and real‐world setting
di: Patrick Juliebø‐Jones, et al.
Pubblicazione: (2024)

Does instrumentation and irrigation configuration affect intrarenal pressure during PCNL?
di: Evan Seibly, et al.
Pubblicazione: (2026)

Cost‐effectiveness of Resonance® metallic ureteral stent compared with standard polyurethane ureteral stents in malignant ureteric obstruction: A cost‐utility analysis
di: Dawn M. Cooper, et al.
Pubblicazione: (2024)

Patient experience of bladder cancer: A data linkage study
di: Snehadhar Shah, et al.
Pubblicazione: (2024)

Health utility value of overactive bladder in Japanese older adults
di: Takashi Yoshioka, et al.
Pubblicazione: (2024)

Outcomes of Aquablation in BPH with bladder stones: Analysis of the ICARUS database
di: Joshua D. Cabral, et al.
Pubblicazione: (2026)

Long‐term outcomes of cutaneous ureterostomy with the aim of stent‐free stoma
di: Chul Jang Kim, et al.
Pubblicazione: (2025)

Perioperative chemotherapy use and related outcomes in muscle‐invasive bladder cancer in Australia
di: Alison Hiong, et al.
Pubblicazione: (2025)

Acu‐URO17 is a highly sensitive and specific bladder cancer biomarker
di: Liwu Guo, et al.
Pubblicazione: (2024)

Comparison of staging MRI to re‐resection for localised bladder cancer: Narrative review
di: Hugo Klempfner, et al.
Pubblicazione: (2024)

Haematuria cancer risk score as a predictor of muscle‐invasive bladder cancer
di: Serdar Turan, et al.
Pubblicazione: (2025)

Predictors of adherence to surveillance cystoscopy for patients with non‐muscle invasive bladder cancer
di: Katherina Y. Chen, et al.
Pubblicazione: (2026)

Understanding symptom contribution to sex inequality in bladder and renal cancer stage at diagnosis
di: Yin Zhou, et al.
Pubblicazione: (2024)

The allium stent for the complex ureteral stricture‐deeper experience of a series case review
di: Hanqi Lei, et al.
Pubblicazione: (2025)

Reliability of mpMRI in diagnosing cancer prostate following intravesical BCG for bladder cancer
di: Arjun Pon Avudaiappan, et al.
Pubblicazione: (2024)

Treatment preferences of patients with muscle invasive bladder cancer: A discrete choice experiment
di: Liam Mannion, et al.
Pubblicazione: (2024)

Novel neoadjuvant therapies for muscle‐invasive bladder cancer: Systematic review and meta‐analysis
di: Shugo Yajima, et al.
Pubblicazione: (2025)

Preoperative FAN score predicts survival outcomes after radical cystectomy for bladder cancer
di: Yu Ishizuya, et al.
Pubblicazione: (2026)

Ureteral stent symptoms: A systematic review and meta‐analysis comparing the use of mirabegron and tamsulosin
di: Daniel Madarshahian, et al.
Pubblicazione: (2025)

Reduced p63 expression is linked to unfavourable prognosis in muscle‐invasive urothelial carcinoma of the bladder
di: Kira Furlano, et al.
Pubblicazione: (2024)

Germline homologous recombination repair (gHRR) variants in bladder cancer: Preliminary evidence and clinical implications
di: Rodolfo Hurle, et al.
Pubblicazione: (2025)

Lymph node dissection during cystectomy for non‐muscle‐invasive bladder cancer: A systematic review
di: Sean Lim, et al.
Pubblicazione: (2026)

The potential role of precision medicine to alleviate racial disparities in prostate, bladder and renal urological cancer care
di: Kunal K. Sindhu, et al.
Pubblicazione: (2024)

Time toxicity of intravesical BCG versus sequential intravesical gemcitabine and docetaxel for non‐muscle‐invasive bladder cancer
di: Jacob Hanna, et al.
Pubblicazione: (2026)

Long non‐coding RNAs define favourable biology in high‐risk non‐muscle‐invasive bladder cancer
di: Rachel Weng, et al.
Pubblicazione: (2025)

Comparing fluorodeoxyglucose positron emission tomography with computed tomography in staging for nodal and distant metastasis in urothelial/bladder cancer
di: Mohammed Al‐Zubaidi, et al.
Pubblicazione: (2024)

Understanding oncological and sexual function outcomes with gynaecological organ preserving cystectomy in women with bladder cancer; a systematic review
di: Rebecca Martin, et al.
Pubblicazione: (2025)

Long‐term outcome of transurethral laser ablation for recurrent non‐muscle invasive bladder cancer: An EORTC risk‐matched study
di: Chase Peng Yun Ng, et al.
Pubblicazione: (2025)

Long‐term follow‐up of intradetrusor botulinum toxin utilisation: A comparison of patients with multiple sclerosis and idiopathic overactive bladder
di: William Chui, et al.
Pubblicazione: (2024)

A systematic review of the patient reported outcomes that affect patients with muscle invasive bladder cancer after radical cystectomy and urinary diversion
di: John Lahoud, et al.
Pubblicazione: (2024)

Real‐world use of maintenance bacillus Calmette‐Guérin therapy in patients with non‐muscle‐invasive bladder cancer in Japan: ASUKA study
di: Makito Miyake, et al.
Pubblicazione: (2025)

Real‐world oncological and toxicity outcomes with the Moscow strain of intravesical BCG for non‐muscle invasive bladder cancer—Implications for global shortage
di: Amandeep Arora, et al.
Pubblicazione: (2025)

Does bladder outflow obstruction obfuscate the traditional clinical factors that are used to assess the risk of prostate cancer at rapid‐access diagnostic clinics?
di: Thomas Philip Cahill, et al.
Pubblicazione: (2024)

Intravesical gemcitabine and docetaxel vs. re‐induction Bacillus Calmette Guerin as first‐line salvage therapy for non‐muscle invasive bladder cancer
di: Kylie Yen‐Yi Lim, et al.
Pubblicazione: (2025)

Understanding the long‐term impact of the COVID‐19 pandemic on non‐muscle‐invasive bladder cancer outcomes: 12‐Month follow‐up data from the international, prospective COVIDSurg Cancer study
di: Cameron E. Alexander, et al.
Pubblicazione: (2024)

Unilateral J‐cut division versus partial and subtotal removal techniques in female patients with mesh‐related urethral obstruction: Multicentric comparative study
di: Bülent Çetinel, et al.
Pubblicazione: (2024)

Targeting genomic receptors in voided urine for confirmation of benign prostatic hyperplasia
di: Mathew Thakur, et al.
Pubblicazione: (2024)

Giant testicular germ‐cell tumours—An analysis of relative incidence and clinical features based on a clinical case series and a survey of the literature
di: Markus Angerer, et al.
Pubblicazione: (2026)

Prognostic factors and treatment impact on overall survival in patients with renal neuroendocrine tumour
di: Olamide O. Omidele, et al.
Pubblicazione: (2024)

Recurrence patterns following nephrectomy for renal cell carcinoma in a Danish nationwide cohort
di: Goran Bencina, et al.
Pubblicazione: (2024)